Bystander effects of cancer cell lines transduced with the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster and synergistic enhancement by hydroxyurea

Molecular Pharmacology

Volumn 60, Issue 2, 2001, Pages 262-266

  Zheng, X ^a   Johansson, M ^a   Karlsson, A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEOSIDE; DEOXYRIBONUCLEOSIDE KINASE; HYDROXYUREA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CYTOTOXICITY; DROSOPHILA MELANOGASTER; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SUICIDE GENE;

EID: 0034923445     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.60.2.262     Document Type: Article

References (34)

1. Prodrug activation enzymes in cancer gene therapy
2. Murine mammary FM3A carcinoma cells transformed with the herpes simplex type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2′-deoxyuridine and related compounds
3. Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases
4. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy
5. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytotoxicity by hydroxyurea
6. Hydroxyurea: Effects on deoxyribonucleotide pool sizes correlated with effects on DNA repair in mammalian cells
7. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
8. Bystander effect of purine nucleoside analogues in HSV-1 tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues
9. Bystander effects of different enzyme-produg systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes
10. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo
11. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro
12. The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified
13. Cloning and characterization of the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster
14. A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma
15. Suicide genes: Past, present and future perspectives
16. Cellular suicide therapy of malignant disease
17. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins
18. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
19. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors
20. Four deoxynucleoside kinase activities from Drosophila melanogaster are contained within a single monomeric enzyme, a new multifunctional deoxynucleoside kinase
21. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy
22. Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant
23. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
24. Herpes simplex virus type 1 and human DNA polymerase interactions with 2′-deoxyguanosine 5′-triphosphate analogues. Kinetics of incorporation into DNA and induction of inhibition
25. Gene therapy for cancer: What have we done and where are we going?
26. Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocultured with herpes simplex virus type 1 thymidine kinase-expressing human glioblastoma cells
27. Successful gene therapy has researchers looking for the bystander effect
28. Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene
29. Mitochondrial versus cytosolic activities of deoxyribonucleoside salvage enzymes
30. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions
31. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component
32. The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions
33. Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells
34. Retroviral transduction of cancer cell lines with the gene encoding Drosophila melanogaster multisubstrate deoxyribonucleoside kinase